CAR-T cells: Early successes in blood cancer and challenges in solid tumors

New approaches to cancer immunotherapy have been developed, showing the ability to harness the immune system to treat and eliminate cancer. For many solid tumors, therapy with checkpoint inhibitors has shown promise. For hematologic malignancies, adoptive and engineered cell therapies are being wide...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Acta Pharm Sin B
Autori principali: Dana, Hassan, Chalbatani, Ghanbar Mahmoodi, Jalali, Seyed Amir, Mirzaei, Hamid Reza, Grupp, Stephan A., Suarez, Eloah Rabello, Rapôso, Catarina, Webster, Thomas J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2021
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8144892/
https://ncbi.nlm.nih.gov/pubmed/34094824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.10.020
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi